Hematology/Oncology
At PPD, hematology and oncology is one of our leading therapeutic areas, from discovery through all phases of development. Our team shares your commitment in the fight against cancer.
Our knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies can significantly impact study efficiency and success.
In the past five years, PPD has conducted or supported approximately 400 hematology/oncology studies that include clinical components, with more than 75,000 patients across a range of tumor types. More than 50 percent of our staff has direct experience in hematology and oncology, which allows us to efficiently guide our clients through all phases of drug development to deliver studies on track, on time and on budget.
Scientific and Medical Expertise
Our hematology and oncology experts across the globe ensure your trials stay on track at any phase of development, from discovery to post-approval.
- Our team of more than 2,500 dedicated hematology and oncology professionals includes medical oncologists, clinical and project managers and clinical research associates, giving clients the benefit of a focused specialty team and the resources of a global company
- Our senior staff of medical directors, board-certified physicians and on-the-ground resources in more than 46 countries provide the critical scientific oversight needed to help clients move smoothly from discovery through all phases of drug development
- Our international oncology advisory board, composed of highly regarded clinical researchers from around the world, provides clients with valuable clinical insights and developmental consulting